FFPE
Biocept Nabs CE-IVD Mark, Makes EGFR Kits Available in Europe
The company said it can now market test kits for both liquid biopsy and FFPE samples to labs in the EU and other participating geographies.
The company plans to outlicense the assay, developed using a custom Affymetrix microarray, to an interested partner.
Biocartis Gets CE Mark for Idylla NRAS-BRAF Mutation Test
The combination of the new test with Biocartis' existing KRAS assay offers customers a complete solution for testing metastatic colorectal cancers as reccomended by professional guidelines.